Skip to main content
PepStack
Blutwerte · Marker

Harnstoff

BUN · Blood Urea Nitrogen · Urea · Harnstoff-N

Nierenwerte
Einheit:
mmol/L
Abbreviation
BUN / Urea

Blood Urea Nitrogen (BUN) quantifies the amount of nitrogen in the blood that comes from urea, a waste product formed in the liver and excreted by the kidneys.

Reference Ranges

Reference
2.57.1mmol/L
2.5
7.1
LowNormalHigh
Reference
Unit · mmol/L

Ranges may vary slightly depending on the laboratory and population. Fasting is not required but hydration status can affect results.

Overview

Übersicht

Urea, commonly measured as Blood Urea Nitrogen (BUN), is a key biomarker for assessing renal function. It is produced in the liver through the urea cycle, a process that converts ammonia, a byproduct of protein metabolism, into urea. Urea is then transported to the kidneys for excretion in urine. Researchers have found that BUN levels can reflect not only kidney health but also other systemic conditions, as urea participates in various physiological systems including the circulatory and nervous systems. Clinically, BUN is a standard test for evaluating renal function, often used alongside creatinine measurements to provide a comprehensive view of kidney health. Elevated BUN levels can indicate renal impairment, dehydration, or increased protein catabolism, while low levels may suggest liver dysfunction or malnutrition. For athletes and biohackers, maintaining optimal BUN levels is crucial for ensuring efficient protein metabolism and kidney function, which are vital for performance and recovery. However, the interpretation of BUN levels requires consideration of several factors. Researchers observed that BUN can be influenced by diet, hydration status, and hormonal changes, making it important to control these variables when testing. Additionally, the BUN-to-creatinine ratio is often used to differentiate between renal and non-renal causes of abnormal BUN levels, providing further diagnostic insight.

Klinische Bedeutung

Elevated BUN levels may indicate renal impairment, dehydration, or increased protein catabolism, while reduced levels can suggest liver dysfunction or malnutrition. It is crucial in assessing kidney function and diagnosing related disorders.

Dynamics

Trend Interpretation

Rising Values

Progressively rising BUN levels may suggest worsening renal function or dehydration. Re-test in 4 weeks if levels are outside the optimal range.

Falling Values

Falling BUN levels could indicate improved hydration or dietary changes, but may also suggest liver dysfunction if too low.

Re-test Interval

4 weeks if outside optimal range

Etiology

Causes — High & Low

Cause

Elevated Levels

  • Renal impairment
  • Dehydration
  • High protein diet
  • Heart failure
  • Gastrointestinal bleeding
Cause

Low Levels

  • Liver dysfunction
  • Malnutrition
  • Overhydration
  • Low protein intake
  • Pregnancy
Protocol

How to Optimize

Lever

Lifestyle

  • Maintain adequate hydration
  • Regular exercise
  • Monitor protein intake
Lever

Nutrition

  • Balanced diet with appropriate protein levels
  • Increase water intake
  • Limit excessive protein consumption

Note:

Consult a healthcare provider before making significant dietary changes, especially if kidney function is compromised.

Testing Guidelines

Fasting Not Required
Not Time-Sensitive

BUN levels may vary throughout the day; morning tests are often preferred.

Testing Frequency

Annually for healthy adults, more frequently if monitoring kidney function.

Interfering Factors

  • High protein diet
  • Dehydration
  • Certain medications

Related Peptides & Hormones

Creatinine

Correlated with

hormone or peptide

Open Research Questions

Current research suggests that the relationship between blood urea nitrogen (BUN) levels and diagnostic delays in conditions like celiac disease remains debated, particularly regarding optimal reference ranges and confounding factors such as gender and disease subtype. Emerging research directions include exploring BUN's predictive value in diabetes progression and its correlation with other biomarkers like GDF15. However, clinical questions remain unanswered regarding the specific mechanisms by which elevated BUN influences diagnostic timelines and disease outcomes.

30 Research Publications

519

Total Citations

20

Human/RCT

2.7

Avg. Influence

2026

Latest

Sort
Filter
#01

Emergence of blood urea nitrogen as a biomarker of neurohormonal activation in heart failure.

ReviewInfluence8.0
223
Researchers discussed the emerging role of blood urea nitrogen (BUN) as a biomarker of neurohormonal activation in heart failure. The study highlighted BUN's potential to indicate renal response to neurohormonal changes, beyond its traditional use in assessing kidney function.
View on PubMed
#02

Association of vancomycin plus piperacillin-tazobactam with early changes in creatinine versus cystatin C in critically ill adults: a prospective cohort study.

HumanInfluence3.0
83
Researchers observed that vancomycin combined with piperacillin-tazobactam increased creatinine levels but did not significantly affect blood urea nitrogen (BUN) or other kidney biomarkers. This suggests that changes in creatinine may represent pseudotoxicity rather than true kidney injury.
View on PubMed
#03

Blood urea nitrogen and creatinine.

HumanInfluence5.0
68
Researchers found that measuring both blood urea nitrogen (BUN) and creatinine levels is crucial for assessing renal function. The study highlighted that BUN levels can be influenced by factors outside the kidneys, emphasizing the need for careful interpretation of results.
View on PubMed
#04

Renal changes and acute kidney injury in covid-19: a systematic review.

Review
34
Researchers conducted a systematic review on renal changes in COVID-19 patients. The review found that increased blood urea nitrogen (BUN) levels were common in patients with acute kidney injury (AKI), indicating significant renal impact from the virus.
View on PubMed
#05

Blood Urea Nitrogen/Albumin Ratio and Mortality Risk in Patients with COVID-19.

HumanInfluence1.0
20
Researchers investigated the relationship between blood urea nitrogen (BUN), albumin, and mortality risk in COVID-19 patients. The study found that higher BUN and albumin ratios were significant predictors of in-hospital mortality, emphasizing their clinical relevance.
View on PubMed
#06

Blood Urea Nitrogen as a Prognostic Marker in Severe Acute Pancreatitis.

HumanInfluence2.0
19
This study found that elevated blood urea nitrogen (BUN) levels were significantly associated with higher mortality rates in patients with severe acute pancreatitis. Researchers established BUN as an independent risk factor for predicting 30-day all-cause mortality.
View on PubMed
#07

A Review of Routine Laboratory Biomarkers for the Detection of Severe COVID-19 Disease.

ReviewInfluence2.0
17
Researchers reviewed laboratory biomarkers for predicting severe COVID-19 disease. They highlighted that blood urea nitrogen (BUN) levels are important indicators of kidney function and disease severity in COVID-19 patients.
View on PubMed
#08

BUN level is associated with cancer prevalence.

HumanInfluence1.0
9
Researchers found a positive correlation between blood urea nitrogen (BUN) levels and cancer prevalence, particularly breast cancer. The study suggests that BUN may serve as an important biomarker in understanding cancer risk.
View on PubMed
#09

Blood urea nitrogen and clinical prognosis in patients with COVID-19: A retrospective study.

HumanInfluence1.0
8
This study assessed the association between blood urea nitrogen (BUN) levels and clinical outcomes in COVID-19 patients. Researchers found that elevated BUN levels were linked to increased 28-day mortality, indicating its potential as a prognostic marker.
View on PubMed
#10

Clinical significance of non-thyroidal illness syndrome on disease activity and dyslipidemia in patients with SLE.

HumanInfluence1.0
7
This study explored the impact of non-thyroidal illness syndrome on disease activity in systemic lupus erythematosus (SLE) patients. Researchers found that blood urea nitrogen (BUN) levels were negatively correlated with disease activity, suggesting its potential as a monitoring tool.
View on PubMed

Clinical Trials (1)

1

Total Trials

70

Total Enrolled

Novel Dose Escalation to Predict Treatment With Hydroxyurea

NCT02042222Early Phase 1COMPLETED
Sponsor

Baylor College of Medicine

Enrollment

70

Started

2013

Primary outcome

Time to patients reaching the maximum tolerated dose (MTD) of the medication

Sickle Cell Disease

Publication Trend

Research publications about Harnstoff over time

10total
1
'86
1
'10
1
'20
1
'21
2
'22
1
'23
1
'24
2
'25

Track your bloodwork in PepStack

Log lab results, track trends and optimize your biomarkers over time.

Legal Disclaimer

This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer